ATAI
there is an unmet need in gad for therapies with rapid onset high efficacy and minimal side effects can fill generalized anxiety disorder favorable safety profile | ATAI
Company
Deck date
October 2022
Slide
29 of 36
Similar slides by ATAI
Investor Presentation
April 2023
Investor Presentation
March 2023
Investor Presentation
February 2023
Investor Presentation
January 2023
Related slides by other companies
IPO
December 2021
Investor Presentation
April 2022
Other recent decks by ATAI
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io